secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001213900-26-048629
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology receives Nasdaq deficiency notice for falling below $1.00 bid price
--------------------------------------------------------------------------------

- Nasdaq notified Citius Oncology on April 22, 2026 that bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 days, until October 19, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may get additional 180 days if meet other standards and intend to cure via reverse stock split.
- Company is evaluating options; stock continues trading under symbol CTOR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390026048629/0001213900-26-048629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390026048629/ea0288020-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-048629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer